Indian drug maker Ranbaxy Laboratories said it is temporarily halting ingredient production at two of its facilities. Ranbaxy has come under scrutiny from the U.S. Food and Drug Administration for lax manufacturing norms.
from WSJ.com: US Business http://ift.tt/1hNhv2m
via IFTTT
from WSJ.com: US Business http://ift.tt/1hNhv2m
via IFTTT
No comments:
Post a Comment